Clinical Trials Browser

OTHER × Waldenstrom Macroglobulinemia × CT-P10 × Clear all

NCT02339922 2026-03-05

Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma

Phase 2 Active not recruiting

33 enrolled 16 charts

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT03269552 2020-01-18

Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma

Phase 2 Terminated

4 enrolled 12 charts

Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone